Respiratory Diagnostics Market Driven by Increasing Prevalence of Respiratory Diseases

Respiratory Diagnostics Market Driven by Increasing Prevalence of Respiratory Diseases

According to the latest IMARC Group report, the global market for respiratory diagnostics reached US$6.9 billion in 2021. Looking ahead, IMARC Group expects the market to reach US$10.9 billion by 2027, showing a growth rate (CAGR) of 7.73% during 2022-2027.

The clinical procedure used to assess lung function and other related conditions is known as respiratory diagnostics, sometimes referred to as a respiratory or pulmonary exam. It is generally performed when the patient experiences chest pain, cough and irritation in the airways, or irregular breathing patterns, among other medical conditions. Respiratory diagnostic procedures include chest radiography, oximetry, inhalation nasal inspiratory pressure (SNIP), computed tomography, and spirometry. Advanced diagnostic methods improve patient management, leading to reduced antibiotic dosage, shorter hospital stays, and minimized health risks.

Competitive scenario with key players:

The competitive landscape of the market has also been analyzed, with some of the key players being

Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics, and COSMED, etc.

Request for a sample copy of this report: https://www.imarcgroup.com/respiratory-diagnostics-market/requestsample

Respiratory Diagnostics Market Trends:

Rapid urbanization, especially in emerging nations, has resulted in sedentary lifestyles and high smoking and tobacco use. Additionally, increasing air pollution in countries such as India and China has accelerated the prevalence of chronic diseases, such as asthma, lung cancer, pulmonary fibrosis, and bronchitis. These factors, along with the growing geriatric population, have catalyzed the demand for respiratory diagnostic devices in hospitals and private clinics. In addition, various technological advances, such as the introduction of advanced molecular diagnostic tests based on artificial intelligence (AI), have positively influenced the efficiency of respiratory diagnostics.

Competitive landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of the key players are Philips Healthcare, Abbott Laboratories (ABT), BIOMERIEUX (BIM.PA), Becton, Dickinson and Company (BDX), Thermo Fisher Scientific, Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI diagnostics, COSMED, etc.

Explore the full report with detailed TOC and a list of figures and tables: https://www.imarcgroup.com/respiratory-diagnostics-market

About us

IMARC Group is a leading market research company providing market research and management strategy worldwide. We partner with clients across industries and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include important market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the pinnacle of the company’s expertise.

Contact Us

30 N Gould St

Ste R

Sheridan, WY 82801

USA

Email: [email protected]

Website: https://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Leave a Comment